What are minor cannabinoids?
Minor cannabinoids are industry breaking compounds, found in small concentrations in cannabis plants. The reason why they are so groundbreaking is extremely exciting – both when isolated or used in formulations, minor cannabinoids show incredible health benefits. In the past, general consensus was that all therapeutic potential is locked in the well known cannabinoids, like CBD. However, as more and more research is done, minor cannabinoids like CBN, THCV, CBC and others, are found to be beneficial for different targets.
The usual problem of minor cannabinoids is that their extraction from the plant is not viable, as there is a risk of also extracting other similar compounds. There is just one real solution – making them in a controlled environment and sparing no effort to ensure their quality and consistency. Sanobiotec does exactly that – we specialize in research and manufacturing of the isolated minor cannabinoids, and are dedicated to producing them in bulk quantities at the highest possible quality.
The differences between major and minor cannabinoids lie not only in their concentration levels within the plant, but also activity towards the endocannabinoid system. Each cannabinoid is unique in that regard, with their structures having minor differences but considerably different effects.
There are over 100 identified minor cannabinoids thus far. Their concentration differs from strain to strain of the plant. It is also affected by many factors including the age of the plant, the growing environment, etc. All of them interact with the body’s endocannabinoid system, exhibiting extraordinary effects and showing incredible therapeutic potential. It does not stop with cannabidiol (CBD) and cannabigerol (CBG). With the market growing so rapidly, the most common cannabinoids list is expanding too, both for research purposes and consumer goods. The most well-known minor cannabinoids are available from Sanobiotec. These include cannabidivarin (CBDV) known for its potential anti-epileptic effects, cannabidiphorol (CBDP) known for pain relief and anti-inflammatory properties, cannabichromene (CBC) that may have antioxidant properties, cannabinol (CBN) that has sedative effects, cannabigerol acid (CBGA) that is the acidic form of the non-psychoactive compound cannabigerol (CBG), and tetrahydrocannabivarin (THCV) which may have appetite suppressing qualities.
List of minor cannabinoids and their effects
Cannabidivarin (CBDV) is one of the non-psychoactive minor cannabinoids that is found in the cannabis plant. It is similar to its better known counterpart, cannabidiol (CBD), but has a shorter alkyl side chain. Studies have shown that CBDV may have potential anti-epileptic effects, making it a possible treatment option for seizures and other neurological conditions.
Cannabidiphorol (CBDP) is an analogue of cannabidiol (CBD) and is one of the most exciting new products on the market. It has been found to relieve pain as an analgesic and may also have anti-inflammatory properties. Research is continuing to fully understand the effects of CBDP on the body.
Cannabichromene (CBC) is a non-psychoactive cannabinoid that is found in the cannabis plant. It has been shown to have antioxidant properties where it may help protect cells from damage and reduce inflammation. Studies have suggested that CBC may have potential as an anti-cancer agent.
Cannabinol (CBN) is a cannabinoid that is produced by CBD oxidation, and is found in older plants. With its structure being so similar to other cannabinoids, it cannot be extracted from hemp. It has been found to have sedative effects, with research suggesting that cannabinol may help with relaxation and sleep. CBN is also thought to have potential as an anti-inflammatory and pain reliever.
Cannabigerol acid (CBGA) is the acidic form of cannabigerol (CBG), a non-psychoactive cannabinoid found in the cannabis plant. CBGA is often referred to as the “mother” or “stem cell” of cannabinoids, as it is the precursor to other cannabinoids like CBG and CBD.
Tetrahydrocannabivarin (THCV) is a cannabinoid that is structurally similar to THC, but is considered non-psychoactive and valued for its biological effects, which include potentially suppressing appetite and may also act as an anticonvulsant.
Sanobiotec is improving the minor cannabinoids market
At Sanobiotec, we understand the potential and the need for minor cannabinoids as the market becomes inundated with unreliable suppliers and products with substandard purity. We are dedicated to improving the market by offering minor cannabinoids worldwide. These are among the most common cannabinoids the market demands. With our in-house research, manufacturing and quality teams, Sanobiotec is built to change the perception of the effect and quality of cannabinoid isolates.. Our work and achievements truly define who we are – a diverse team of persistent thinkers and achievers.
Our R&D facility pushes boundaries in the field of cannabinoids through partnership with national and educational institutions. Our work with the National Cancer Institute of Lithuania includes extraction and synthesis of minor cannabinoids and derivatives in an attempt to tackle specific cancers. Another partnership connects us with the Life Science Centre of Vilnius University – our colleagues in the development of recombinant yeast strains to produce cannabinoids biosynthetically and to perform in vivo experiments.
Decades of accumulated experience and knowledge allow us to provide you with a ready supply of both natural and semi-synthetic compounds at the highest purity levels. Purity, we believe, is the key customer satisfaction factor in the wellness, cosmetics and food related markets.